1. Pharmaxis
2. Home
3. About Us

About Us

Pharmaxis is a specialty pharmaceutical company involved in the research, development and commercialisation of new therapies for undertreated respiratory diseases.

Our first product, Aridol, is now registered for sale in Australia, Europe and South East Asia and a request for marketing approval has been filed in the United States. Aridol is designed to assist in the management of both asthma and chronic obstructive pulmonary disease.

Our second product, Bronchitol, has completed the first regulatory Phase 3 trials in both cystic fibrosis and bronchiectasis.

We are committed to bringing our therapeutic advances for respiratory and immune diseases to patients throughout the world, and to building an internationally successful pharmaceutical business: one that's built to last.

Company overview